Literature DB >> 12894228

Regulation of NF-kappaB2/p100 processing by its nuclear shuttling.

Gongxian Liao1, Shao-Cong Sun.   

Abstract

Processing of the NF-kappaB2 precursor protein p100 to generate p52 is an important step of NF-kappaB regulation. This proteolytic event is tightly regulated by sequences located at the C-terminal portion of p100. Constitutive processing of p100 occurs in certain lymphoma cells due to the loss of its C-terminal regulatory domain, although the underlying mechanisms remain unknown. We show here that the constitutive processing of C-terminal truncation mutants of p100 is associated with their active nuclear translocation. Deletion of the C-terminal death domain of p100 triggers a low, but significant, level of nuclear translocation and processing. Disruption of the ankyrin-repeat domain of p100 further enhances its nuclear shuttling activity, which is again associated with elevated level of processing. More importantly, mutation of the nuclear localization signal (NLS) of p100 abolishes its processing, and this defect can be rescued by fusion of a heterologous NLS to the amino- or carboxyl-terminus of the p100 mutant. These results suggest that nuclear shuttling is a mechanism regulating the processing of NF-kappaB2/p100.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12894228     DOI: 10.1038/sj.onc.1206761

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

Review 1.  Nuclear initiated NF-κB signaling: NEMO and ATM take center stage.

Authors:  Shigeki Miyamoto
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

2.  Endoproteolytic processing of C-terminally truncated NF-kappaB2 precursors at kappaB-containing promoters.

Authors:  Guoliang Qing; Zhaoxia Qu; Gutian Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-15       Impact factor: 11.205

3.  Preventing abnormal NF-κB activation and autoimmunity by Otub1-mediated p100 stabilization.

Authors:  Yanchuan Li; Jin-Young Yang; Xiaoping Xie; Zuliang Jie; Lingyun Zhang; Jianhong Shi; Daniel Lin; Meidi Gu; Xiaofei Zhou; Haiyan S Li; Stephanie S Watowich; Antrix Jain; Sung Yun Jung; Jun Qin; Xuhong Cheng; Shao-Cong Sun
Journal:  Cell Res       Date:  2019-05-13       Impact factor: 25.617

Review 4.  Regulation of NF-κB by TNF family cytokines.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Semin Immunol       Date:  2014-06-21       Impact factor: 11.130

Review 5.  The noncanonical NF-κB pathway.

Authors:  Shao-Cong Sun
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

Review 6.  Non-canonical NF-κB signaling pathway.

Authors:  Shao-Cong Sun
Journal:  Cell Res       Date:  2010-12-21       Impact factor: 25.617

7.  Tumor-derived p53 mutants induce NF-kappaB2 gene expression.

Authors:  Mariano J Scian; Katherine E R Stagliano; Michelle A E Anderson; Sajida Hassan; Melissa Bowman; Mike F Miles; Swati Palit Deb; Sumitra Deb
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

8.  SN52, a novel nuclear factor-kappaB inhibitor, blocks nuclear import of RelB:p52 dimer and sensitizes prostate cancer cells to ionizing radiation.

Authors:  Yong Xu; Fang Fang; Daret K St Clair; Pradoldej Sompol; Sajni Josson; William H St Clair
Journal:  Mol Cancer Ther       Date:  2008-08       Impact factor: 6.261

Review 9.  Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology.

Authors:  Sören Beinke; Steven C Ley
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

10.  Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.

Authors:  Micah Luftig; Teruhito Yasui; Vishal Soni; Myung-Soo Kang; Nils Jacobson; Ellen Cahir-McFarland; Brian Seed; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.